A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (RANGE)

Aragon-ching J.,Asch A.,Beck J.,Bellmunt J.,Burke J.,Cultrera J.,Dichmann R.,Doshi G.,Drakaki A.,Flaig T.,Hainsworth J.,Hancock M.,Herms B.,Kendall S.,Kohli M.,Lawler W.,Lowe T.,Matrana M.,Mcknight J.,Oje...

A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

Acs P.,Albany C.,Babu S.,Beck J.,Bendell J.,Courtney K.,Dreicer R.,Kozloff M.,Nimeh N.,Percent I.,Sartor A.,Shore N.,Smukler A.,Sweeney C.,Tsai F.,Waterhouse D.,Zhao S.

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (MONARCH 2)

Panwalkar, A.,Tiersten, A.,WHITTENBERGER, B.,Stokoe, C.,Jones, C.,Patt, D.,Tamkus, D.,Khan, D.,Khan, F.,Holmes, F.,Wright, G.,Sledge, G.,Wang, G.,Koh, H.,Soliman, H.,Rugo, H.,Reynolds, J.,Vu, J.,Beck, J.,...

Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.

Yacoub, A.,Rodney, A.,Brown, A.,Powell, B.L.,Baltz, B.,Bank, B.,Jones, C.M.,Nguyen, D.D.,Aly, E.M.,Dean, E.W.,Roboz, G.J.,Garcia-Manero, G.,Rivero, G.,Oliff, I.,Shammo, J.,Burke, J.,Wallmark, J.,Beck, J.T...

Open-label, Phase II Study of Stomatitis Prevention With a Steroid-based Mouthwash in Post-menopausal Women With Estrogen-receptor-positive (ER+), Human Epidermal Growth Factor Receptor 2 (HER2)- Metastatic or Locally Advanced Breast Cancer

Forero-Torres, A.,Yee, A.K.,Haley, B.,Rexer, B.N.,Nangia, C.,Zarwan, C.,Melancon, D.,Ellis, E.,Schwartz, G.,Rugo, H.S.,Carney, J.,Litton, J.,Glaspy, J.A.,Beck, J.T.,Peguero, J.,Ward, K.,Seneviratne, L.,Hw...

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Beck, J.T.,Fury, M.G.

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Hurvitz, S.A.,Rugo, H.S.,Mayer, I.,Beck, J.M.,Blackwell, K.L.,Vaklavas, C.,Dees, E.C.,Blau, S.,Liu, M.C.,Danso, M.A.,Mayer, E.L.,Wilks, S.T.,Wolff, A.C.,Holmes, F.A.,Gradishar, W.,McIntyre, K.J.,O'Regan, ..

A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck Cancer

Beck, J.T.,Harb, W.

Phase Ib/II Study of Buparlisib Plus Carboplatin or Lomustine in Patients With Recurrent Glioblastoma Multiforme

Beck, J.M.,Ashby, L.,Shtivelband, M.I.,Wen, P.Y.,Raizer, J.

LGX818 for Patients With BRAFV600 Mutated Tumors (SIGNATURE)

Johnson, M..,Salgia, R.,Gersten, T.A.,Frank, R.C.,Chawla, S.P.,Beck, J.M.,Peguero, J.A.,Brose, M.S.,Taylor, M.H.

A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1) (MONALEESA-1)

Schwartzberg, L.S.,Bardia, A.,Hoskins, K.,Hurvitz, S.A.,Beck, J.M.,Forero-Torres, A.,Meric-Bernstam, F.